Gemcitabine and cisplatin (GP) induction chemotherapy (IC) plus concurrent chemoradiotherapy (CCRT) versus CCRT alone in locoregionally advanced nasopharyngeal carcinoma (NPC): A phase 3, multicenter, randomized controlled trial.-MedSci.cn

Gemcitabine and cisplatin (GP) induction chemotherapy (IC) plus concurrent chemoradiotherapy (CCRT) versus CCRT alone in locoregionally advanced nasopharyngeal carcinoma (NPC): A phase 3, multicenter, randomized controlled trial.

Ma, J; Zhang, Y; Sun, Y; Xie, FY; Hu, WH; Hu, GQ; Zhang, N; Yang, KY; Zhu, XD; Jin, F; Cheng, ZB; Shi, M; Han, F; Tian, Y; Sun, Y; Mo, HY; Li, JG

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (15):

科室
- - 订阅+
  - 更多科室
工具
服务